Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The short-term effects of excessive drinking are well known, but to date it has been less certain whether alcohol also accelerates the aging process.

Wine pouring onto brain from bottle © Mischa Hafferty

Today, researchers from Oxford Population Health  and the Department of Psychiatry have published results from a new genetic-based analysis which suggest that alcohol directly accelerates ageing by shortening telomeres. The findings are published today in Molecular Psychiatry. Read the Full Story on the University's News Page

Primary Investigator, Dr Anya Topiwala from Oxford Population Health, said:

 

‘These findings support the suggestion that alcohol, particularly at excessive levels, directly affects telomere length. Shortened telomeres have been proposed as risk factors which may cause a number of severe age-related diseases, such as Alzheimer’s disease. Our results provide another piece of information for clinicians and patients seeking to reduce the harmful effects of excess alcohol. Furthermore, the dose of alcohol is important – even reducing drinking could have benefits.’

Prof. Klaus Ebmeier from the Department of Psychiatry, added:

 

'This is one in a series of Oxford studies in the large UK Biobank data set that suggest even "normal" drinking comes with a risk of faster ageing, impaired mental, and physical brain health. All who consume alcohol need to balance this against their potential enjoyment of having a drink.'

Read the full story on the University of Oxford website.

Read the full paper Alcohol consumption and telomere length: Mendelian randomization clarifies alcohol’s effects.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Tackling Suicide Risk in People With Mental Disorders

Clinical researchers from Oxford University’s Department of Psychiatry and Oxford Health NHS Foundation Trust, together with colleagues from elsewhere, have developed guidance to help clinicians identify and treat patients at risk of suicide.

New Meta-Analysis Highlights No Antidepressant Effect of Statins Administered in Monotherapy

This new systematic review and meta-analysis of randomised controlled trials assesses the effects of statins given alone, without concomitant antidepressant treatment, in people with depressive symptoms, but who do not have a formal diagnosis of a depressive disorder.

New Oxford Study Evaluates Pharmacological Treatment for Insomnia

Two drugs, eszopiclone and lemborexant – both not currently licenced for the treatment of insomnia in the UK – were shown to perform better than others, both in the acute and long-term treatment of insomnia in adults, according to a new Oxford study exploring the pharmacological management of insomnia.

Moderate Drinking Linked to Brain Iron and Cognitive Decline

Consumption of seven or more units of alcohol per week is associated with higher iron levels in the brain. Iron accumulation in the brain has been linked with Alzheimer's and Parkinson's diseases and is a potential mechanism for alcohol-related cognitive decline.

Effectiveness of School-Based Mindfulness Training

A standardised schools-based mindfulness training programme did not help young people’s mental health and well-being overall, but did improve school culture and reduce teachers’ burn out, a research team led by the University of Oxford has found.